Flufenamic acidFlufenamic acid - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-B1221-01.804-HY-B1221-01804-HY-B1221-01Business & Industrial > Science & LaboratoryFlufenamic acid
Gentaur
EUR12027-02-25

Flufenamic acid

CAT:
804-HY-B1221-01
Size:
100 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Flufenamic acid - image 1

Flufenamic acid

  • Description:

    Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca2+ channels, modulating non-selective cation channels (NSC), activating K+ channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.
  • UNSPSC:

    12352005
  • Hazard Statement:

    H301, H315, H319
  • Target:

    AMPK; Calcium Channel; Chloride Channel; COX; Parasite; Potassium Channel
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection; Epigenetics; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling; PI3K/Akt/mTOR
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/Flufenamic-acid.html
  • Concentration:

    10mM
  • Purity:

    99.93
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C(O)C1=CC=CC=C1NC2=CC=CC(C(F)(F)F)=C2
  • Molecular Formula:

    C14H10F3NO2
  • Molecular Weight:

    281.23
  • Precautions:

    H301, H315, H319
  • References & Citations:

    [1]Guinamard R, et al. Flufenamic acid as an ion channel modulator. Pharmacol Ther. 2013 May;138 (2) :272-84.|[2]Pongkorpsakol P, et al. Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation. Eur J Pharmacol. 2017 Mar 5;798:94-104.|[3]Pongkorpsakol P, et al. Cellular mechanisms underlying the inhibitory effect of flufenamic acid on chloride secretion in human intestinal epithelial cells. J Pharmacol Sci. 2017 Jun;134 (2) :93-100.|[4]Pobbati AV, et al. Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy. Structure. 2015;23 (11) :2076-2086.|[5]Fan Yang, et al. Topical Application of Butyl Flufenamate Ointment Promotes Cranial Defect Healing in Mice by Inducing BMP2 Secretion in Skin Mesenchymal Stem Cells. Cells. 2022 Nov 15;11 (22) :3620.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Launched
  • Isoform:

    L-type calcium channel
  • CAS Number:

    [530-78-9]